Enhanced Therapeutic Potential of Adoptive Immunotherapy by In Vitro CD28/4-1BB Costimulation of Tumor-Reactive T Cells Against a Poorly Immunogenic, Major Histocompatibility Complex Class I-Negative A9P MelanomaScott E. Strome, Lieping Chen, Andrei I. Chapoval et al.|Journal of Immunotherapy|2000Cited by 39
Generation of Therapeutic T-Lymphocytes After In Vivo Tumor Transfection with an Allogeneic Class I Major Histocompatibility Complex GeneWendy L. Wahl, Alfred E. Chang, Gary J. Nabel et al.|Journal of Immunotherapy|1995Cited by 22
Enhancement of Immune Reactivity in the Lymph Nodes Draining a Murine Melanoma Engineered to Elaborate Interleukin-4John C. Krauss, Suyu Shu, Scott E. Strome et al.|Journal of Immunotherapy|1994Cited by 20
Secretion of Both IL-2 and IL-4 by Tumor Cells Results in Rejection and ImmunityScott E. Strome, John C. Krauss, Alfred E. Chang et al.|Journal of Immunotherapy|1996Cited by 5
Strategies of Lymphocyte Activation for the Adoptive Immunotherapy of Metastatic Cancer: A ReviewScott E. Strome, Suyu Shu, John C. Krauss et al.|Journal of Hematotherapy|1993Cited by 4